HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Late-onset Erythropoietic Protoporphyria Associated with Myelodysplastic Syndrome Treated with Azacitidine.

AuthorsAi Yoshioka, Susumu Fujiwara, Hiroki Kawano, Hajime Nakano, Shigeru Taketani, Toshimitsu Matsui, Yoshio Katayama, Chikako Nishigori
JournalActa dermato-venereologica (Acta Derm Venereol) Vol. 98 Issue 2 Pg. 275-277 (Feb 07 2018) ISSN: 1651-2057 [Electronic] Sweden
PMID29057424 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Enzyme Inhibitors
  • Azacitidine
Topics
  • Aged
  • Azacitidine (therapeutic use)
  • Disease Progression
  • Enzyme Inhibitors (therapeutic use)
  • Humans
  • Male
  • Myelodysplastic Syndromes (complications, diagnosis, drug therapy)
  • Protoporphyria, Erythropoietic (diagnosis, drug therapy, etiology)
  • Skin (drug effects, pathology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: